A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis
Clinical trial NCT00034476 · COMPLETED
Trial details
- NCT number
- NCT00034476
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-10-01
- Enrollment
- 466
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.